Se-Il Go

Se-Il Go

Auto-generated profile, based on publicly available information

Se-Il Go

Gyeongsang National University College of Medicine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in European Journal of Cancer
Verified
Journal Article
Closed access
SGSe-Il Go
Se-Il Go
SLSang-Cheol Lee
Sang-Cheol Lee
WBWoo Kyun Bae
Woo Kyun Bae
DZDae Young Zang
Dae Young Zang
HLHyun Woo Lee
Hyun Woo Lee
JKJung Hun Kang
Jung Hun Kang

1 March 2025 in Journal of hospice and palliative care
Verified
Journal Article
Open access
PDF file
SGSe-Il Go
Se-Il Go
MKMYOUNGHEE KANG
MYOUNGHEE KANG
HKHoon-Gu Kim
Hoon-Gu Kim
Se-Il Go, M.D.1, Myoung Hee Kang, M.D.1 and Hoon-Gu Kim, M.D., Ph.D.. J Hosp Palliat Care 2025;28:10-7. https://doi.org/10.14475/jhpc.2025.28.1.10

1 March 2023 in The Korean Journal of Hospice and Palliative Care
Verified
Journal Article
Open access
PDF file
SGSe-Il Go
Se-Il Go
JKJung-Hoon Hoon Kim
Jung-Hoon Hoon Kim
JKJung Hun Kang
Jung Hun Kang
Se-Il Go, M.D., Jung Hoon Kim, M.D., Ph.D. and Jung Hun Kang, M.D., Ph.D.. J Hosp Palliat Care 2023;26:18-21. https://doi.org/10.14475/jhpc.2023.26.1.18

10 March 2022 in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Verified
Journal Article
Open access
PDF file
YYYaewon Yang
Yaewon Yang
HKHong Jun Kim
Hong Jun Kim
SGSe-Il Go
Se-Il Go
WBWoo Kyun Bae
Woo Kyun Bae
ESEun-Kee Song
Eun-Kee Song
HHHye Sook Han
Hye Sook Han
Background/Aims: Peritoneal carcinomatosis with malignant ascites is common in patients with advanced gastric cancer (GC). The detection of tumor cells is the gold standard for the diagnosis of malignant ascites; however, it often requires complementary tests because of its low sensitivity. Herein, we measured the levels of tumor markers in the malignant ascites of GC patients (GC-ascites) and benign ascites of liver cirrhosis patients (LC-ascites) to elucidate the diagnostic value of tumor markers in GC-ascites.Materials and Methods: The levels of CEA, cancer antigen 72-4 (CA 72-4), CA 19-9, and CA 125 were measured in 138 GC-ascites and 64 LC-ascites samples obtained from the National Biobank of Korea. We performed receiver operating characteristic curve analysis to determine the optimal cutoff value for each tumor marker.Results: CEA, CA 72-4, and CA 19-9 levels were significantly higher in GC-ascites than in LC-ascites. There was no difference in tumor marker levels between GC-ascites samples irrespective of cytology. CEA, CA 72-4, and CA 19-9 had sensitivities of 85.5%, 79.0%, and 61.6%, respectively, and specificities of 96.8%, 100.0%, and 89.1%, respectively, for distinguishing GC-ascites samples from LC-ascites samples. The diagnostic accuracy was improved by combining two or more tumor markers. The combination of CEA and CA 72-4 showed the highest sensitivity (86.2%) and specificity (100%).Conclusions: Measurement of tumor markers, such as CEA, CA 72-4, and CA 19-9, in ascites samples could help diagnose GC-ascites, and combining two or more tumor markers could further increase the diagnostic yield, even in cytology-negative patients.

19 July 2024 in The Oncologist
Verified
Journal Article
Open access
PDF file
JKJung Hun Kang
Jung Hun Kang
KLKyung Hee Lee
Kyung Hee Lee
SHSeok Jae Huh
Seok Jae Huh
SSSeong-Hoon Shin
Seong-Hoon Shin
IKIl Hwan Kim
Il Hwan Kim
SGSe-Il Go
Se-Il Go
The physical dependence on prescription opioids among cancer survivors remains an under-investigated area, with a scarcity of well-designed prospective studies. This single-arm, phase-2 clinical trial in Korea assessed the efficacy and safety of a transdermal buprenorphine patch (TBP) in managing physical dependence on prescription opioids in cancer survivors, as confirmed through the DSM-5 criteria or psychiatric consultation for opioid withdrawal. This study involved a 4-phase treatment protocol of screening, induction/stabilization, discontinuation, and monitoring. The primary outcome was the rate of successful opioid discontinuation, as measured by a negative urine-drug screening at 8 weeks. Key secondary outcomes included the resumption of prescribed opioids, changes in both the Clinical Opioid Withdrawal Scale (COWS) and morphine equivalent daily dose (MEDD), and assessments related to the psychological and physiological aspects of dependence and safety. Thirty-one participants were enrolled. In the intention-to-treat population, the success rate of opioid discontinuation was 58%, with only 2 participants experiencing a resumption of prescribed opioids. Significant reductions were observed in MEDD, which decreased from 98 to 26 mg/day (P < .001), and COWS scores, which decreased from 5.5 to 2.8 (P < .001). Desire to use opioids reduced from 7.0 to 3.0 on a 10-point numeric rating scale (P < .001). Toxicities related to TBP were mild and manageable, without severe precipitated withdrawal symptoms. TBP may be considered as an alternative therapeutic option in cancer survivors physically dependent on prescription opioids, especially where sublingual formulations are unavailable.

10 January 2022 in Journal of the Korean Medical Association
Verified
Journal Article
Open access
PDF file
SGSe-Il Go
Se-Il Go
YWYoung-Woong Won
Young-Woong Won
JKJung Hun Kang
Jung Hun Kang
Background: Opioids are effective analgesics for cancer pain and refractory non-cancer pain. Although they are essential medication, problematic issues on aberrant behavior and adverse events have rapidly emerged as social problems in Korea. This study aimed to describe the mechanisms, efficacy, and adverse events, especially how to deal with opioid dependency.Current Concepts: Opioid-induced aberrant behavior includes physical and psychological dependences (addiction), abuse, and diversion (giving prescribed opioids to another person). Most physicians are unfamiliar with how to handle patients presenting these problematic issues. Physical and psychological dependences develop through different pathophysiologic mechanisms, i.e., noradrenergic and dopaminergic pathways, respectively. Motivational enhancement therapy, psychosocial support, substitution therapy with buprenorphine, and adjunctive medications, including alpha-2 adrenergic agonist, antidepressants, and non-steroidal antiinflammatory drugs, are the mainstay of treatment for opioid dependency. Constipation, nausea/vomiting, drowsiness/sedation, delirium, itching sensation, voiding difficulty, dry mouth, opioid-induced hyperalgesia, and respiratory depression are well-known physical side effects of opioid consumption.Discussion and Conclusion: Research on the development history, epidemiology of opioid dependency, and its treatment are warranted to avoid an opioid crisis in Korea. Above all, thorough knowledge for physicians and patients is urgently needed.